Technical Articles
Fc Chimera
FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera Protein: A Green Navigation Beacon for Immunotherapy in Multiple Myeloma
FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera Protein is a high-performance fluorescently labeled fusion protein with critical value in immunotherapy research for hematologic malignancies such as multiple myeloma.
View details
- Cancer
- SLAMF7/CRACC/CD319
- Fc Chimera
- Multiple Myeloma
- Hematologic Malignancies
- 1













